IVD devices enable earlier breast cancer diagnoses than mammograms, and detect genetic abnormalities that can contribute to ...
Zacks Investment Research on MSN
Tempus AI Enhances Cancer Research Tools With FDA-Cleared xR IVD
RNA sequencing provides a comprehensive view of biological information, offering deeper insights into disease mechanisms, including improved fusion detection. As a powerful tool in research and ...
RALEIGH, N.C.--(BUSINESS WIRE)--Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry, announced today that it has acquired an ...
Tempus AI shares are trading higher Monday morning. The company announced it has received U.S. Food and Drug Administration ...
More Lenient Guidelines May Inadvertently Lead to a Scarcity of Consented Samples Recently, no area has contributed more and increasingly complex layers to the bioethics debate than research employing ...
Dublin, Nov. 13, 2020 (GLOBE NEWSWIRE) -- The "Medical Device & IVD Regulatory Affairs Outsourcing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030" report has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback